Cogent Biosciences Inc (COGT) financials · $5.75B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Cogent Biosciences Inc (COGT) $5.75B cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$333.4M | -$275.9M |
| Net Income | -$328.9M | -$255.9M |
| EPS (Diluted) | -$2.16 | -$1.94 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $937.6M | $327.9M |
| Current Assets | $910.4M | $296.5M |
| Cash & Equivalents | $312.0M | $98.2M |
| PP&E | $5.46M | $6.47M |
| Total Liabilities | $301.2M | $71.6M |
| Current Liabilities | $64.0M | $55.7M |
| Long-term Debt | $222.9M | N/A |
| Total Debt | $222.9M† | N/A |
| Shareholders' Equity | $636.4M | $256.3M |
| Retained Earnings | -$1.19B | -$859.5M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$264.4M | -$207.8M |
| CapEx | $1.55M | $573.0K |
| Investing Cash Flow | -$399.5M | $38.3M |
| Financing Cash Flow | $878.2M | $214.5M |
| Net Change in Cash | $214.3M | $44.9M |
| Free Cash Flow | -$266.0M | -$208.4M |
FAQ
What is COGT P/E and revenue?
Cogent Biosciences Inc (COGT) $5.75B cap.
What is COGT revenue?
COGT income-statement cache has no revenue figure yet.
Is COGT profitable?
Cogent Biosciences Inc last cached net income is -$328.9M (FY2025).
What are COGT total assets?
Cogent Biosciences Inc last cached total assets are $937.6M (FY2025).
What is COGT free cash flow?
Cogent Biosciences Inc last cached free cash flow is -$266.0M (FY2025).
Not investment advice. Cached statements, not a live tape.